COVID-19 pandemic in Russia

Russian politician, Prime Minister of Russian Federation

ongoing COVID-19 viral pandemic in Russia

ongoing COVID-19 viral pandemic in Crimea

plan to immunize against COVID-19

ongoing COVID-19 viral pandemic in Sevastopol

thumb|right|R-Pharm logo R-Pharm () is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik (ru) in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the comp